Kenichi W. Okamoto

Dr. Kenichi W. Okamoto

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2014 in Journal of Theoretical Biology
Verified
Journal Article
Closed access
KOKenichi W. Okamoto
Kenichi W. Okamoto
PAPriyanga Amarasekare
Priyanga Amarasekare
IPIan T.D. Petty
Ian T.D. Petty

14 October 2022 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
SKSophia E Kruger
Sophia E Kruger
PLPaul A. Lorah
Paul A. Lorah
KOKenichi W. Okamoto
Kenichi W. Okamoto
Several studies have investigated howVibrio choleraeinfection risk changes with increased rainfall, temperature, and water pH levels for coastal Bangladesh, which experiences seasonal surges in cholera infections associated with heavy rainfall events. While coastal environmental conditions are understood to influenceV.choleraepropagation within brackish waters and transmission to and within human populations, it remains unknown how changing climate regimes impact the risk for cholera infection throughout Bangladesh. To address this, we developed a random forest species distribution model to predict the occurrence probability of cholera incidence within Bangladesh for 2015 and 2050. We developed a random forest model trained on cholera incidence data and spatial environmental raster data to be predicted to environmental data for the year of training (2015) and 2050. From our model’s predictions, we generated risk maps for cholera occurrence for 2015 and 2050. Our best-fitting model predicted cholera occurrence given elevation and distance to water. Generally, we find that regions within every district in Bangladesh experience an increase in infection risk from 2015 to 2050. We also find that although cells of high risk cluster along the coastline predominantly in 2015, by 2050 high-risk areas expand from the coast inland, conglomerating around surface waters across Bangladesh, reaching all but the northwestern-most district. Mapping the geographic distribution of cholera infections given projected environmental conditions provides a valuable tool for guiding proactive public health policy tailored to areas most at risk of future disease outbreaks.

19 October 2020 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
BHBrandon Hollingsworth
Brandon Hollingsworth
KOKenichi W. Okamoto
Kenichi W. Okamoto
Alun LloydAlun Lloyd
Alun Lloyd
The lack of effective vaccines for many endemic diseases often forces policymakers to rely on non-immunizing control measures, such as vector control, to reduce the massive burden of these diseases. Controls can have well-known counterintuitive effects on endemic infections, including the honeymoon effect, in which partially effective controls cause not only a greater initial reduction in infection than expected, but also large outbreaks during control resulting from accumulation of susceptibles. Unfortunately, many control measures cannot be maintained indefinitely, and the results of cessation are poorly understood. Here, we examine the results of stopped or failed non-immunizing control measures in endemic settings. By using a mathematical model to compare the cumulative number of cases expected with and without control, we show that deployment of control can lead to a larger total number of infections, counting from the time that control started, than without any control–the divorce effect. This result is directly related to the population-level loss of immunity resulting from non-immunizing controls and is seen in a variety of models when non-immunizing controls are used against an infection that confers immunity. Finally, we examine three control plans for minimizing the magnitude of the divorce effect in seasonal infections and show that they are incapable of eliminating the divorce effect. While we do not suggest stopping control programs that rely on non-immunizing controls, our results strongly argue that the accumulation of susceptibility should be considered before deploying such controls against endemic infections when indefinite use of the control is unlikely. We highlight that our results are particularly germane to endemic mosquito-borne infections, such as dengue virus, both for routine management involving vector control and for field trials of novel control approaches, and in the context of non-pharmaceutical interventions aimed at COVID-19. Many common endemic infections lack effective, inexpensive vaccinations, and control relies instead on transmission reduction, e.g. mosquito population reduction for dengue. Often, these controls are used with the immediate goal of decreasing the current incidence with little importance placed on what will happen at later points in time, and much less what will happen once the control is stopped. Here, by looking at the cumulative incidence since the beginning of the control period, instead of the instantaneous incidence, we show that when controls are stopped, or fail, the resulting outbreaks can be large enough to completely eliminate any benefit of the control. We call this result the divorce effect. Further, we show that this result is not limited to specific transmission pathways or epidemiological parameters, but is instead tied directly to the reduction of herd immunity inherent in non-immunizing controls. Lastly, by evaluating programs to minimize the magnitude of the divorce effect, we show that without maintaining herd immunity, or successfully continuing control for decades, it is impossible to keep the costs of post-control outbreaks from outweighing the benefits of the control program. We note that our results have significance in the context of non-pharmaceutical interventions aimed at COVID-19.

25 August 2015 in Biological Journal of the Linnean Society
Verified
Journal Article
Closed access
PDF file
KOKenichi W. Okamoto
Kenichi W. Okamoto
RLR. Brian Langerhans
R. Brian Langerhans
RRRezoana Rashid
Rezoana Rashid
PAPriyanga Amarasekare
Priyanga Amarasekare

10 March 2016 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
KOKenichi W. Okamoto
Kenichi W. Okamoto
FGFred Gould
Fred Gould
Alun LloydAlun Lloyd
Alun Lloyd
Many vector-borne diseases lack effective vaccines and medications, and the limitations of traditional vector control have inspired novel approaches based on using genetic engineering to manipulate vector populations and thereby reduce transmission. Yet both the short- and long-term epidemiological effects of these transgenic strategies are highly uncertain. If neither vaccines, medications, nor transgenic strategies can by themselves suffice for managing vector-borne diseases, integrating these approaches becomes key. Here we develop a framework to evaluate how clinical interventions (i.e., vaccination and medication) can be integrated with transgenic vector manipulation strategies to prevent disease invasion and reduce disease incidence. We show that the ability of clinical interventions to accelerate disease suppression can depend on the nature of the transgenic manipulation deployed (e.g., whether vector population reduction or replacement is attempted). We find that making a specific, individual strategy highly effective may not be necessary for attaining public-health objectives, provided suitable combinations can be adopted. However, we show how combining only partially effective antimicrobial drugs or vaccination with transgenic vector manipulations that merely temporarily lower vector competence can amplify disease resurgence following transient suppression. Thus, transgenic vector manipulation that cannot be sustained can have adverse consequences—consequences which ineffective clinical interventions can at best only mitigate, and at worst temporarily exacerbate. This result, which arises from differences between the time scale on which the interventions affect disease dynamics and the time scale of host population dynamics, highlights the importance of accounting for the potential delay in the effects of deploying public health strategies on long-term disease incidence. We find that for systems at the disease-endemic equilibrium, even modest perturbations induced by weak interventions can exhibit strong, albeit transient, epidemiological effects. This, together with our finding that under some conditions combining strategies could have transient adverse epidemiological effects suggests that a relatively long time horizon may be necessary to discern the efficacy of alternative intervention strategies. Despite decades of attempted vector control, several vector-borne diseases remain endemic. Recent high-profile studies suggest that candidate vaccines, particularly for dengue, may be less than completely effective as public health interventions. Nevertheless, the epidemiological consequences of using other novel approaches (e.g., transgenic strategies to reduce or replace vector populations) remain highly uncertain. Faced with unclear prospects of any one strategy succeeding in isolation, there is increasing interest in designing a comprehensive public health response to manage vector-borne diseases. Here we use a relatively simple model to study how combining vaccines, transgenic vector manipulation and antimicrobial medications can facilitate disease management. We explain why the epidemiological consequences for combining strategies are not expected to merely sum their effects. Contrary to the prevailing assumption that comprehensive disease management always yields public health benefits, we find integrating transgenic vector manipulation with clinical interventions can, in some cases, temporarily exacerbate the adverse consequences of any one strategy failing. These results highlight the need for system-specific modeling efforts aimed at assessing whether our conclusions apply to specific vector-borne diseases. We outline the implications for proceeding with public health responses integrating currently available products, as well as assessing their efficacy.

20 January 2016 in Evolution
Verified
Journal Article
Closed access
PDF file
BWBrian R. Wasik
Brian R. Wasik
AMAndrés R. Muñoz-Rojas
Andrés R. Muñoz-Rojas
KOKenichi W. Okamoto
Kenichi W. Okamoto
KMKathryn Miller-Jensen
Kathryn Miller-Jensen
PTPaul Turner
Paul Turner